Trials / Completed
CompletedNCT02881840
Mass-balance Study of [14C]-APD421 in Healthy Volunteers
An Open Label, Single Dose, Single Period Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] APD421 Administered Via the Intravenous Route to Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Acacia Pharma Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Open-label, non-randomised, single dose study in 6 healthy male subjects to assess the mass balance recovery, metabolite profile, metabolite identification and pharmacokinetics of 14C-labelled APD421
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 14C-APD421 |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2016-08-29
- Last updated
- 2019-06-25
- Results posted
- 2019-06-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02881840. Inclusion in this directory is not an endorsement.